Skip to main content
Erschienen in: The Journal of Headache and Pain 1/2015

Open Access 01.12.2015 | Poster presentation

P013. 25(OH)D Level and headache in children sample

verfasst von: Elisabetta Tozzi, Alessandra Boncristiano, Annarita Antenucci, Simona Di Loreto, Giovanni Farello

Erschienen in: The Journal of Headache and Pain | Sonderheft 1/2015

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Statistical significance between serum 25(OH)D levels and headache in the pediatric population is still controversial. However, a supplementary vitamin D therapy in children with headache allowed us to note an improvement in the clinical symptoms in terms of frequency and severity[1].

Aim

To study vitamin D blood levels in primary headaches and to show the relationship with clinical parameters influencing clinical course of the headache.

Materials and methods

Sixty-seven males (42%) and 92 females (58%), aged between 5 to 18 years, suffering from headache, were divided into three diagnostic categories, according to the ICHD-III classification: migraine with aura (MWA), migraine without aura (MWoA) and tension-type headache (TTH). Serum vitamin D level lower than 20 ng/ml was considered pathological. Immunohistochemical methods of chemiluminescence were used to determine blood 25(OH)D level.

Results

Ninety-one patients (57%) received a diagnosis of MWoA, 32 (20%) of MWA and 36 (23%) of TTH. Hypovitaminosis D was found in 56% of the children with MWoA, in 50% of patients with MWA and in 44.4% with TTH. Twelve percent of all the sample showed severe Hypovitaminosis D (<10 ng/ml). There were neither statistically significant differences comparing vitamin D serum levels between males and females in each category of headache (p = 0.36), nor more severe deficiency of vitamin D in overweight children with BMI>90°C (p = 0.47), and serum concentration was not lower in adolescents and pre-adolescent than children under 10 years. A difference resulted in the limits of statistical significance (p = 0.07) in 25(OH)D serum level in children with MWoA compared to patients with MWA and THH.

Conclusions

Our study shows a high incidence of vitamin D deficiency in the pediatric population with headache (56%), particularly in migraineurs without aura[2]. Probably this deficiency could be directly correlated with a higher frequency of migraine attacks in children with MWoA.
Written informed consent to publication was obtained from the patient(s).

Acknowledgments

We thank Professor Stefano Necozione for the statistic analysis.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://​creativecommons.​org/​licenses/​by/​4.​0), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Literatur
1.
Zurück zum Zitat Cayir A, et al: Effect of vitamin D in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res. 2014, 47: 349-54. 10.1590/1414-431X20143606.PubMedCentralCrossRefPubMed Cayir A, et al: Effect of vitamin D in addition to amitriptyline on migraine attacks in pediatric patients. Braz J Med Biol Res. 2014, 47: 349-54. 10.1590/1414-431X20143606.PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Mottaghi T, et al: The relationship between serum levels of vitamin D and migraine. J Res Med Sci. 2013, 18: S66-70.PubMedCentralPubMed Mottaghi T, et al: The relationship between serum levels of vitamin D and migraine. J Res Med Sci. 2013, 18: S66-70.PubMedCentralPubMed
Metadaten
Titel
P013. 25(OH)D Level and headache in children sample
verfasst von
Elisabetta Tozzi
Alessandra Boncristiano
Annarita Antenucci
Simona Di Loreto
Giovanni Farello
Publikationsdatum
01.12.2015
Verlag
Springer Milan
Erschienen in
The Journal of Headache and Pain / Ausgabe Sonderheft 1/2015
Print ISSN: 1129-2369
Elektronische ISSN: 1129-2377
DOI
https://doi.org/10.1186/1129-2377-16-S1-A84

Weitere Artikel der Sonderheft 1/2015

The Journal of Headache and Pain 1/2015 Zur Ausgabe

Invited speaker presentation

Genomics and epigenomics

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.